Northstar Medical Technologies, LLC
Beloit, WI
- UEI
- RP3JVPT94155
- CAGE
- 50SY6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 1800 Gateway Blvd, Beloit, WI 53511, USA
- Website
- northstarnm.com
- Founded
- 2006
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Niowave, Inc. | Lansing, MI | 325412 Pharmaceutical Preparation Manufacturing |
| Eckert & Ziegler Nuclitec Inc. | Wilmington, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Pharmalogic WY Inc. | Bridgeport, WV | 325412 Pharmaceutical Preparation Manufacturing |
| Jubilant Radiopharma | Kirkland, QC | 325412 Pharmaceutical Preparation Manufacturing |
| Heartlight Pharmacy Services | Lima, OH | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Northstar Medical Technologies, LLC is a manufacturer of radiopharmaceuticals, including Mo-99 for diagnostic imaging and cancer treatment, based on the description from its website. NorthStar Medical Radioisotopes provides global access to game-changing radiopharmaceuticals.
Through multiple cooperative agreements from the Department of Energy National Nuclear Security Administration, Northstar Medical Technologies has received significant funding to scale up production of Mo-99 using two different methods: the neutron capture process with enriched molybdenum-98 target material, and the electron accelerator irradiation process with enriched molybdenum-100 target material. The projects involve obtaining approval for next-generation separation systems, establishing automated target dissolution and filling systems, completing scale-up of recovery and reclamation processes to reclaim enriched target materials, installing quality control equipment, and acquiring additional enriched target materials. These efforts aim to increase production capacity, accelerate product release, and reduce raw material costs. The total funding awarded for these projects exceeds $495 million over a three-year period from 2021 to 2024. Prior to these awards, Northstar Medical Technologies received a $30 million cooperative agreement from 2019 to 2022 to support its Mo-99 production efforts.
Quick answers
Is Northstar Medical Technologies, LLC registered in SAM.gov?
Yes. Northstar Medical Technologies, LLC's SAM.gov registration is active through January 2, 2027.
What is Northstar Medical Technologies, LLC's most recent federal award?
Northstar Medical Technologies, LLC's most recent federal grant award is Northstar intends through this effort to complete scale-up production of MO-99 via the neutron capture process using… (DENA0004011), from National Nuclear Security Administration, on September 2, 2021.
On GovTribe
See Northstar Medical Technologies, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors